In this section, the experimental results will be presented and analyzed for three scenarios: intraspinal ependymoma, low-grade glioma in the brain, and cirrhosis with multiple nodules. The evaluation focuses on changes in diagnostic accuracy, rationality, comprehensiveness in differential diagnosis, and clinical feasibility with and without RAG technology support, expert comparisons of initial diagnoses and diagnostic analysis, and case-specific analysis.
5.1. Case 1
5.1.1. LLM-MID Diagnostic Result:
The most likely diagnosis is spinal cord tumor. It is recommended to perform further pathological examination to clarify the tumor’s nature and formulate a targeted treatment plan.
a. Diagnostic Basis:
The patient has an oval-shaped lesion in the spinal cord at the center, with cystic changes and hemorrhage inside the tumor, which is characteristic of spinal cord tumors. The enhanced scan shows significant enhancement with clear borders, supporting the diagnosis of spinal cord tumor. The notable swelling and surrounding edema of the spinal cord indicate that the lesion exerts significant pressure and causes inflammation in the spinal cord. This may lead to neurological dysfunction, such as bilateral lower limb weakness.
b. Differential Diagnosis:
①. Myelitis: May cause spinal cord swelling and inflammation, but typically does not present with the intramedullary oval-shaped lesion, cystic changes, and hemorrhage seen in this case. ②. Spinal Vascular Malformation: Can lead to spinal cord swelling, but generally does not involve intramedullary lesions, and the lesion is vascular in nature. ③. Multiple Sclerosis: A demyelinating disease that can cause spinal cord dysfunction, but the lesions are typically multiple, and do not present as an intramedullary oval-shaped lesion with cystic changes and hemorrhage.
5.1.2. LLM-RAG-MID Diagnostic Result:
The most likely diagnosis is spinal ependymoma. It is recommended to proceed with prompt surgery for definitive pathological diagnosis and to develop an individualized treatment plan based on the latest clinical guidelines and research. Post-surgery rehabilitation is required to promote neurological function recovery, with regular follow-up to monitor for recurrence or progression.
a. Diagnostic Basis:
The patient is a 59-year-old female, within the typical age range for spinal ependymoma (40-60 years). The symptom of progressive bilateral lower limb weakness aligns with the clinical presentation of spinal ependymoma.
The lesion is centrally located in the spinal cord, consistent with common locations for spinal ependymomas. The tumor shows cystic changes and hemorrhage, with significant enhancement on contrast scans, clear borders, and surrounding edema, all matching the imaging characteristics of spinal ependymoma.
b. Differential Diagnosis:
①. Spinal Astrocytoma: May cause spinal cord swelling and dysfunction but is more common in children and adolescents. The imaging usually shows irregular shapes, less cystic degeneration, and minimal hemorrhage, with uneven enhancement and unclear borders. This patient’s age and imaging features do not align with spinal astrocytoma. ②. Hemangioblastoma: A vascular tumor more common in younger individuals, presenting with large cysts and small nodules with significant enhancement. This patient lacks these imaging characteristics. ③. Spinal Cavernous Hemangioma: Known for recurrent bleeding, with mixed signal intensity on imaging, indicating old hemorrhage and minimal enhancement. The patient lacks a bleeding history and the imaging features are inconsistent. ④. Spinal Metastasis: Typically presents with a history of primary tumors and rapid symptom progression. Imaging shows significant enhancement and notable surrounding edema. This patient has no history of primary tumors and her symptoms are progressing slowly. ⑤. Myelitis: Acute or subacute onset, often with an infection or autoimmune history. Imaging shows spinal cord swelling, signal changes, with no obvious mass lesion, and may show irregular enhancement. The patient’s gradual onset and the clear space-occupying lesion on imaging rule out this diagnosis.
5.1.3. Diagnostic Strategy and Decision Optimization
Based on the detailed analysis of the imaging characteristics, the LLM-RAG-MID system integrated imaging findings and clinical information more thoroughly after training, optimizing the diagnostic process. The traditional LLM diagnosis summarized the condition as “spinal cord tumor,” but did not specify the type of tumor. Its differential diagnosis included myelitis, spinal vascular malformation, and multiple sclerosis, diseases that could cause spinal cord swelling or dysfunction but did not match the key features of this case. The improved diagnosis clearly identified spinal ependymoma as the most likely diagnosis, based on the patient’s age, progressive bilateral lower limb weakness, and imaging showing a centrally located intramedullary lesion with cystic changes, hemorrhage, and significant enhancement. The enhanced differential diagnosis focused on more relevant diseases, such as spinal astrocytoma, hemangioblastoma, spinal cavernous hemangioma, and spinal metastasis, providing a detailed analysis of the differences between each disease and this case. This resulted in a more targeted, logically rigorous, and professionally advanced diagnosis, providing a solid foundation for developing an effective treatment plan.
5.2. Case 2
5.2.1. LLM-MID Diagnostic Result:
The most likely diagnoses are cerebral cysticercosis (particularly in the viable cyst stage) or brain glioma (although cysticercosis seems more likely considering the MRS results). The final diagnosis should integrate the patient’s medical history, physical examination, laboratory tests, and possibly cerebrospinal fluid analysis.
a. Diagnostic Basis:
Patient’s age and symptoms: The patient is a young female with a 3-month history of headache and seizures, suggesting a central nervous system disorder. MRI findings: The lesion is located in the right temporal lobe. T1WI shows uniform low signal, T2WI and FLAIR show uneven high signals, suggesting fluid content or cystic changes. No significant enhancement on the contrast scan suggests the lesion is not vascular or actively inflammatory. Surrounding edema and mass effect indicate significant pressure on surrounding tissue. MRS results: The NAA peak is significantly reduced, and the Cho peak is significantly increased, with Cho/NAA = 1.94. This pattern is typical for cysticercosis, especially when the cysts are viable, as cysticercosis contains large amounts of choline, while neuronal damage decreases NAA.
b. Differential Diagnosis:
①. Brain Glioma: Usually shows irregular signal changes on MRI, possibly with cystic degeneration, hemorrhage, or necrosis. Gliomas, particularly malignant ones, typically show significant enhancement. MRS may also show increased Cho and decreased NAA peaks, but not as markedly as in cysticercosis. ②. Brain Abscess: Often presents with an infection history and ring-like enhancement on MRI with central liquefaction. Clinical symptoms may include fever, headache, and nausea. ③. Cerebral Hemorrhage or Infarction: Cerebral hemorrhage shows high signal on T1WI (subacute phase) and low signal on T2WI (acute phase) with significant mass effect. Infarction shows low signal on T1WI and high signal on T2WI, usually with cerebrovascular disease evidence. ④. Brain Metastasis: Typically has a history of primary tumors in other locations. MRI shows nodular lesions with enhancement on contrast scans.
5.2.2. LLM-RAG-MID Diagnostic Result:
The most likely diagnosis is low-grade astrocytoma (WHO grade II). Key differential diagnoses include cysticercosis and other intracranial tumors. Detailed history-taking, careful analysis of imaging features, and necessary laboratory tests will help clarify the diagnosis.
a. Diagnostic Basis:
The patient is 35 years old, which falls within the typical age range for low-grade astrocytoma (30-40 years). Symptoms: Recurrent seizures and persistent headaches, which are consistent with the typical symptoms of low-grade astrocytoma. The disease duration is 2 years with slow progression, consistent with low-grade astrocytoma’s typical course. No history of epidemiological exposure or systemic symptoms, which helps exclude cysticercosis. MRI findings: The lesion is located in the white matter of the cerebral hemisphere (e.g., frontal or temporal lobe), showing isointense or low signal on T1WI, high signal on T2WI, and high signal on FLAIR, with indistinct borders and infiltrative growth, difficult to distinguish from surrounding brain tissue. Mild to moderate finger-like edema with mild mass effect. Enhancement scan: No significant enhancement or only mild patchy enhancement, consistent with low-grade astrocytoma. MRS features: A significant reduction in the NAA peak indicates neuronal damage or loss. The Cho peak is significantly increased, suggesting increased cell membrane synthesis and turnover, with active cell proliferation. The Cho/NAA ratio is elevated, typically greater than 1, supporting a tumor diagnosis.
b. Differential Diagnosis:
①. Cysticercosis: No history of undercooked pork consumption or living in endemic areas. Symptoms: No systemic symptoms such as fever, fatigue, or elevated eosinophils. Imaging features: Cysticercosis usually presents with multiple lesions, widely distributed, with cysts showing a “head stage” (dot sign), whereas low-grade astrocytoma is a single lesion with no “head stage.” Lab tests: No cysticercosis antibodies in serum or cerebrospinal fluid, and no elevated eosinophils in peripheral blood. ②. Other Intracranial Tumors: High-grade astrocytoma, meningioma, lymphoma, etc., may show different imaging features, such as clearer borders, more prominent enhancement, and greater mass effect. However, based on the clinical presentation, imaging features, and MRS results, these tumors can be ruled out.
5.2.3. Diagnostic Strategy and Decision Optimization
In the improved diagnosis, a more professional and accurate diagnostic approach was shown. Initially, cysticercosis was favored as the most likely diagnosis, mainly based on the patient’s MRI and MRS results. However, this judgment overlooked typical epidemiological and imaging features of cysticercosis, such as multiple cystic lesions, the “head stage” (dot sign), and the patient’s possible infection history. In the improved RAG configuration, LLM correctly identified low-grade astrocytoma (WHO grade II) as the most likely diagnosis. This conclusion was based on multi-dimensional analysis: accurate clinical feature assessment: the physician noted the patient’s age and symptoms matched the typical presentation of low-grade astrocytoma, such as recurrent seizures and persistent headaches, with slow disease progression and no infection-related systemic symptoms. Detailed imaging feature analysis: The improved diagnosis fully utilized MRI and contrast scan details, identifying a single solid lesion with indistinct boundaries, infiltrative growth, and finger-like edema, all of which were consistent with low-grade astrocytoma, ruling out cysticercosis. Proper interpretation of MRS metabolic features: The physician correctly interpreted the significantly lowered NAA peak and the increased Cho peak as metabolic characteristics of a tumor, recognizing that an elevated Cho/NAA ratio typically indicates active cell proliferation, not parasitic infection. Rigorous differential diagnosis: The physician systematically excluded cysticercosis and other intracranial tumors, providing strong opposing evidence, such as the lack of epidemiological exposure, no multiple cystic lesions, absence of the “head stage,” and no abnormal lab results.
5.3. Case 3
5.3.1. LLM-MID Diagnostic Result:
The most likely diagnosis is hepatocellular carcinoma (Hepatocellular Carcinoma, HCC) with multiple intrahepatic nodules, including typical HCC nodules, hypervascular nodules, and necrotic cystic nodules. Key differential diagnoses include intrahepatic cholangiocarcinoma, liver metastasis, cirrhotic nodules, and hepatic hemangioma.
a. Diagnostic Basis:
Patient information and clinical presentation: The patient is a 36-year-old male with a 2-month history of fatigue. Although his age is not typical for liver cancer, clinical and imaging findings are more critical. Liver morphology and parenchymal changes: The liver edge is undulating, and the liver parenchyma shows diffuse small nodules, suggesting potential diffuse liver disease. MRI signal characteristics: The diffuse small nodules show isointense to slightly high signal on T1WI and isointense to slightly low signal on T2WI. No enhancement in the arterial phase, and isointense or slightly low signal in the portal venous and equilibrium phases, suggesting cirrhosis or small non-active nodules. The right anterior liver lobe nodule shows uniform signal with significant enhancement in the arterial phase and isointense signal in the portal venous phase, consistent with typical enhancement patterns for hepatocellular carcinoma. The right posterior liver lobe nodule shows uneven signal with a “nodule within a nodule” appearance, significant enhancement in the arterial phase, and reduced enhancement in the portal venous phase, suggesting necrosis or cystic degeneration, a common feature in hepatocellular carcinoma.
b. Differential Diagnosis:
①. Intrahepatic Cholangiocarcinoma (ICC): Typically shows a mass at the liver edge with low signal on T1WI, high signal on T2WI, and mild enhancement in the arterial phase, with uneven enhancement in the portal venous or delayed phase. The enhancement pattern of ICC differs from that of HCC, and bile duct dilation is more common. ②. Liver Metastasis: Usually has a history of primary tumors, with multiple round or oval lesions showing smooth edges, low signal on T1WI, high signal on T2WI, and “target sign” or ring-like enhancement on contrast scans. ③. Cirrhotic Nodules: May present as multiple liver nodules, but usually smaller, homogeneous, with minimal enhancement, and lacking the characteristic enhancement pattern of HCC. ④. Hepatic Hemangioma: Shows low signal on T1WI, high signal on T2WI, and a “blooming artifact” appearance, with “fast in, slow out” enhancement on contrast scans, which is distinct from the enhancement pattern of HCC.
5.3.2. LLM-RAG-MID Diagnostic Result:
The most likely diagnosis is hepatocellular carcinoma (advanced stage) with cirrhosis and multiple intrahepatic nodules (including regenerative nodules, low-grade dysplastic nodules, and possibly early hepatocellular carcinoma nodules).
a. Diagnostic Basis:
The patient is a middle-aged male with persistent fatigue, which is a common clinical feature of hepatocellular carcinoma.
The undulating liver edge suggests cirrhosis. The right anterior liver nodule exhibits the typical “fast in, fast out” enhancement pattern of hepatocellular carcinoma. The right posterior liver nodule shows uneven signal with a “nodule within a nodule” appearance, with arterial phase enhancement and reduced signal in the portal venous phase, highly suggestive of hepatocellular carcinoma. The diffuse small nodules likely represent regenerative nodules or low-grade dysplastic nodules in the context of cirrhosis.
b. Differential Diagnosis:
①. Regenerative Nodules: Typically smaller than 3mm, homogeneous in signal, isointense on T1WI and T2WI, with no or mild enhancement. While the diffuse small nodules here show some characteristics of regenerative nodules, the right anterior and posterior liver nodules do not fit this diagnosis. ②. Low-Grade Dysplastic Nodules: Similar signal characteristics to regenerative nodules but slightly larger, with no significant enhancement. The nodules in this case show enhancement, ruling out this diagnosis. ③. High-Grade Dysplastic Nodules: May show mild enhancement but lack “washout.” The nodules in this case exhibit the characteristic “fast in, fast out” enhancement pattern, ruling this out. ④. Other Liver Tumors: Intrahepatic cholangiocarcinoma, liver metastasis, etc., show different enhancement patterns and signal characteristics from hepatocellular carcinoma and lack the “nodule within a nodule” appearance.
5.3.3. Diagnostic Strategy and Decision Optimization
The diagnosis generated with the RAG configuration showed significant improvements in professionalism, accuracy, and comprehensiveness. The improved diagnosis clearly identified “hepatocellular carcinoma (advanced stage) with cirrhosis and multiple intrahepatic nodules (including regenerative nodules, low-grade dysplastic nodules, and possibly early hepatocellular carcinoma nodules),” emphasizing the advanced stage of HCC and providing a detailed description of the multiple intrahepatic nodules, demonstrating a deep understanding of liver disease complexity. The diagnostic basis is more systematic and rigorous. The physician integrated clinical features with imaging findings, highlighting cirrhosis and thoroughly analyzing the imaging characteristics and pathological significance of each nodule, thus improving diagnostic accuracy. The differential diagnosis is more thorough and logically sound. The physician systematically excluded benign or premalignant lesions, such as regenerative nodules, low-grade dysplastic nodules, and high-grade dysplastic nodules, based on imaging features and enhancement patterns, providing strong supporting evidence to exclude these possibilities. Additionally, the diagnosis considered other liver tumors, reflecting a comprehensive approach to differential diagnosis. Finally, the expression is more academic and professional. The improved diagnosis used specialized medical terminology, making the expression clear, accurate, and logically rigorous, in line with academic writing conventions, facilitating better communication in clinical and research settings.
Overall, these three case analyses show that the improvements made through learning documents significantly enhanced the diagnostic ability of the large language model (LLM), particularly in terms of accuracy, differential diagnosis comprehensiveness, and clinical decision support. By integrating key medical information using deep learning, the system accurately synthesizes clinical presentation, imaging features, and auxiliary test results, promoting multidisciplinary consultations and optimizing treatment pathways. The improved diagnosis reflects a higher level of professionalism, more comprehensive content, stronger evidence, and more academic expression, providing robust support for clinical decision-making and academic research.